Eradicating Helicobacter pylori reduces hypergastrinaemia during long term omeprazole treatment

Gut

Volumn 42, Issue 2, 1998, Pages 159-165

  El Nujumi, A ^a   Williams, C ^a   Ardill, J E ^b   Oien, K ^a   McColl, K E L ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Helicobacter pylori; Hypergastrinaemia; Omeprazole

Indexed keywords

OMEPRAZOLE;

ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; GASTRIN BLOOD LEVEL; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HYPERGASTRINEMIA; LONG TERM CARE; MALE; PRIORITY JOURNAL;

EID: 0031898903     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.2.159     Document Type: Article

References (39)

1. Koop H, Klein M, Arnold R. Serum gastrin levels during long-term omeprazole treatment. Aliment Pharmacol Ther 1990;4:131 8.
2. Banerjee S, El-Omar E, Mowat A, et al. Sucralfate suppresses Helicobacter pylori infection and reduces acid secretion by 50% in patients with duodenal ulcer. Gastroenterology 1996;170:717 25.
3. Lind T, Cederberg C, Idstrom JP, Lonroth H, Olbe L, Lundell L. 24-Hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis. Scand J Gastroenterol 1991;26:620 6.
4. Creutzfeldt W, Stockmann F, Conlon JM, Folsch UR, Bonatz G, Wulfrath M. Effect of short and long-term feeding of omeprazole on rat gastric endocrine cells. Digestion 1986;35(suppl 1):84 97.
5. Larsson H, Carlsson E, Hakanson R, et al. Time course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1988;95:1477 86.
6. Koop H, Willemer S, Steinbach F, Eissele R, Tuch K, Arnold R. Influence of chronic drug-induced achlorhydria by substituted benzimidazoles on the endocrine stomach of rats. Gastroenterology 1987;92:406 13.
7. Ekmann L, Hansson E, Havu N, Carlsson E, Lundberg C. Toxicological studies on omeprazole. Scand J Gastroenterol 1985;20(Suppl. 108):53-69.
8. Betton GR, Dormer CS, Wells T, Pert P, Price CA, Buckley P. Gastric ECL-cell hyperplasia and carcinoids in rodents following chronic administration of H -antagonists SK&F 93479 and oxmetidine and omeprazole. Toxicol Pathol 1988;16:288 98.
9. Eissele R, Patberg H, Koop H, et al. Effect of gastrin receptor blockade on endocrine cells in rats during achlorhydria. Gastroenterology 1992;103:1596 601.
10. Creutzfeldt W, Lamberts R. Is hypergastrinaemia dangerous to man? Scand J Gastroenterol 1991;180(suppl):179 91.
11. Lamberts R, Creutzfeld W, Struber HG, Brunner G, Solcia E. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth and gastritis. Gastroenterology 1993;104:1356 70.
12. Kusyk CJ, McNeil NO, Johnson LR. Stimulation of growth of a colon cancer cell line by gastrin. Am J Physiol 1986;25: 9597 601.
13. Ishizuka J, Martinez J, Townsend CM, Thompson JC. The effect of gastrin on growth of human stomach cancer cells. Ann Surg 1992;215:528 35.
14. Watson SA, Steele RJC. Gastrin antagonists in the treatment of gastric cancer. Anticancer Drugs 1993;4:599 604.
15. Rehfeld JF. Gastrin and colorectal cancer; a never-ending dispute? Gastroenterology 1995;108:1307 9.
16. Chittajallu RS, Ardill JES, McColl KEL. The degree of hypergastrinaemia induced by Helicobacter pylori is the same in duodenal ulcer patients and asymptomatic volunteers. Eur J Gastroenterol Hepatol 1992;4:49 53.
17. Veldhuyzen van Zanten SJO, Pollak PT, Best LM, Bezanson GS, Marrie T. Increasing prevalence of Helicobacter pylori infection with age: continuous risk of infection in adults rather than cohort effect. J Infect Dis 1994;169:434 7.
18. Marshall BJ, Warren R, Francis GJ, Langton SR, Goodwin CS, Blincow ED. Rapid urease test in the management of Campylobacter pyloridis associated gastritis. Am J Gastroenterol 1987;82:200 10.
19. Mulholland G, Ardill JES, Fillmore D, Chittajallu RS, Fullarton GM, McColl KEL. Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17. Gut 1993;34:757 61.
20. Veenendaal RA, Lichtendal-Bernards AT, Pena AS, Endtz HP, van Boven CP, Lamers CB. Effect of transport medium and transportation time on culture of Helicobacter pylori from gastric biopsy specimens. J Clin Pathol 1993;46:561 3.
21. Jones DM, Lessels AM, Eldridge J. Campylobacter-like organisms on the gastric mucosa: culture, histological and serological studies. J Clin Pathol 1984;37:1002 6.
22. McColl KEL, El Nujumi AM, Dorrian CA, Macdonald AMI, Fullarton GM, Harwood J. Helicobacter pylori and hypergastrinaemia during proton pump inhibitor therapy. Scand J Gastroenterol 1992;27:93-8.
23. Koop H, Klein M, Arnold R. Serum gastrin levels during long-term omeprazole treatment. Aliment Pharmacol Ther 1990;4:131 8.
24. Jansen JBMJ, Klinkenberg-Knol EC, Meuwissen SGM, et al. Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology 1990;99: 621 8.
25. McColl KEL, Fullarton GM, Chittajallu R, et al. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol 1991;26:339-46.
26. Penston JG, Dixon JS, Selway SAM, Wormsley KG. Gastric histology and plasma gastrin response to a meal in patients with duodenal ulcer disease after five years treatment with ranitidine. Aliment Pharmacol Ther 1990;4:381 92.
27. Lind T, Cederberg C, Idstrom J P, Lonroth H, Olbe L, Lundell L. 24-Hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis. Scand J Gastroenterol 1991;26:620 6.
28. Odum D, Petersen HD, Andersen IB, Hansen BF, Rehfeld JF. Gastrin and somatostain in Helicobacter pylori infected antral mucosa. Gut 1994;35:615 18.
29. Kaneko H, Nakada K, Mitsuma T, et al. Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentrations of human stomach. Dig Dis Sci 1992;37:409-16.
30. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992;340:930-2.
31. Lucey MR, Yamada T. Biochemistry and physiology of gastrointestinal somatostatin. Dig Dis Sci 1989;34:5S-13S.
32. Tarnasky PR, Kovacs TOG, Sytnik B, Walsh JH. Asymptomatic H pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation. Dig Dis Sci 1993;38:1681-7.
33. Verdu EF, Armstrong D, Fraser R, et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995;36:539-43.
34. Verdu E F, Armstrong D, Idstrom J-P, et al. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995;37:743-8.
35. Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995;36:12-16.
36. Kuipers EJ, Kinkenberg-Knol EC, Havu N, et al. Helicobacter pylori and development of atrophic gastritis during omeprazole maintenance therapy [abstract]. Gastroenterology 1995;108:A137.
37. Kuipers EJ, Lee A, Klinkenberg-Knol EC, Meuwissen SGM. Review article: the development of atrophic gastritis Helicobacter pylori and the effects of acid suppressive therapy. Aliment Pharmacol Ther 1995;9:331-40.
38. Weil J, Bell DG, Powell K, et al. Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication. Aliment Pharmacol Ther 1991;5:309 13.
39. Hui WM, Lam SK, Ho J, et al. Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci 1991;36:577 82.